doi: 10.1542/peds.113.4.e360
These peptides support healthy metabolism, lean muscle development, fat metabolism, and overall vitality
Public awareness of GLP-1 therapies continues to grow, particularly because of weight management benefits, which may increase patient interest in these medications
On the basis of current guidelines, GLP-1 RAs should be considered in patients with T2DM and CVD or CV risk factors
It protects against UVB, UVA II, and UVA I almost uniformly, and is considered to be the broadest range sunscreen available today
Conventional T2D treatments, including Sodium-Glucose Co-transporter-2 inhibitors (SGLT2 inhibitors), metformin, sulfonylureas, dipeptidyl peptidase 4 inhibitors (DPP-4 inhibitors), and insulin, primarily focus on glycemic control but exert varying and often modest effects on the underlying inflammatory state (11)